Scientists are turning a spotlight on China’s version of the origins of the coronavirus pandemic as they scrutinize everything from the virus’s genetic code to proxy data, such as cremations and internet searches for disease symptoms.

British researchers will study the genes of thousands of ill COVID-19 patients to try to crack one of the most puzzling riddles of the novel coronavirus: why does it kill some people but give others not even a mild headache?

Cambridge, Massachusetts-based Moderna is one of the first companies to move a vaccine against COVID-19 into clinical trials.

AstraZeneca made further headway in a race with competitor GlaxoSmithKline to use a promising new class of drugs to treat ovarian cancer.

The Nasdaq indicated that there was a record amount of biotech initial public offerings (IPOs) in 2018, totaling around $8.2 billion raised, breaking 2014’s record of $6.5 billion.

Scientists launched a vast project to map the genetic code of all 1.5 million known species of complex life on earth, aiming to complete the work within a decade.

Scientists have assembled the most complete human genome to be mapped with a single technology using a new pocket-size portable DNA sequencer, which they say could one day make genome mapping quick and simple enough to do at home.